Company news

Latigo Biotherapeutics, Inc. news

Latest news releases, newest first.

View company

Latigo Biotherapeutics to Participate in Upcoming Investor Conferences in November

November 3, 2026

LTGO: Onzotrigine delivers rapid, superior pain relief with strong opioid-sparing potential in late-stage trials

September 3, 2026

Latigo Biotherapeutics Price Target Announced at $36.00/Share by Leerink Partners

September 1, 2026

Latigo Biotherapeutics Ups IPO to 19.2 Million Shares

August 7, 2026

Decks